Immunization in children opghai All necessary information

Reading File
“Immunization in children” is a large topic. Using the usual OP Ghai-style pediatric approach, it includes:
  1. Basic concepts: active vs passive immunization, types of vaccines, herd immunity, cold chain.
  2. National Immunization Schedule: birth through adolescence, including catch-up vaccination.
  3. Individual vaccines: BCG, hepatitis B, OPV/IPV, DPT-containing vaccines, Hib, rotavirus, pneumococcal, measles-rubella/MMR, Japanese encephalitis, HPV, typhoid, influenza, and others.
  4. Practical administration: dose, route, site, spacing, simultaneous administration, documentation.
  5. Contraindications and precautions: true contraindications versus common myths.
  6. Adverse events following immunization: expected minor reactions, serious events, initial management and reporting.
  7. Special situations: preterm infants, malnutrition, missed doses, immunocompromised children, travel, pregnancy in household contacts.
  8. Vaccine storage and cold chain.
  9. Communication with parents: vaccine hesitancy and counseling.
At a high level, childhood immunization protects the child before exposure to serious infections, and high community coverage also reduces transmission to vulnerable people. The schedule and products differ by country, so for clinical use it should be aligned with the current national program.
Which section should I write as detailed exam notes first?
  1. Full National Immunization Schedule
  2. All vaccines with dose-route-site-age
  3. Contraindications, AEFI, and cold chain
  4. Special situations and catch-up vaccination

All information say

Reading File
A complete OP Ghai-style note on childhood immunization is too large for one useful message. I can cover it systematically in these sections:
  1. Principles of immunization
    • Active and passive immunization
    • Live and inactivated vaccines
    • Herd immunity, vaccine efficacy/effectiveness
    • Combination vaccines and simultaneous administration
  2. India National Immunization Schedule
    • Birth to 16 years
    • Age, dose, route, site, and disease prevented
    • UIP vaccines and commonly recommended optional vaccines
  3. Individual vaccine notes
    • BCG, hepatitis B, OPV, IPV, pentavalent/DPT, Hib
    • Rotavirus, PCV, MR/MMR, JE
    • Typhoid, hepatitis A, influenza, HPV, varicella, rabies, meningococcal vaccines
  4. Catch-up immunization
    • Missed doses
    • Minimum ages and minimum intervals
    • Rules for interrupted schedules
  5. Contraindications and precautions
    • True contraindications
    • False contraindications, such as mild fever, cough/cold, malnutrition, breastfeeding, and antibiotic use
  6. AEFI
    • Expected local/systemic reactions
    • Anaphylaxis and emergency management
    • Reporting and observation after vaccination
  7. Cold chain and vaccine handling
    • Temperature requirements
    • Vaccine vial monitor
    • Open-vial policy
    • Freeze-sensitive vaccines and shake test
  8. Special situations
    • Preterm and low-birth-weight infants
    • Immunodeficiency/HIV
    • Children on steroids, chemotherapy, or biological agents
    • Household contacts of immunocompromised children
    • Travel immunization
Reply with a section number, for example “2”, and I will give detailed exam-ready notes for that section.

1 and 3

Finding Sources
Finding Sources
Finding Sources
Searching PubMed

childhood immunization

Searching the Web

India National Immunization Schedule 2025 child vaccination official UIP PDF

Finding Sources
Finding Sources
Finding Sources
Reading Web Page

https://prod-cdn.preprod.co-vin.in/uwin-prod/pdf/National+Im…

Reading File
Reading File
Reading File
Reading File

Immunization in Children: Principles and Individual Vaccines

This is an exam-oriented pediatric note, aligned mainly with the Indian National Immunization Schedule (NIS/UIP). The current NIS includes BCG, hepatitis B, OPV, pentavalent, fractional IPV, rotavirus vaccine, PCV, MR, JE in endemic areas, DPT boosters, and Td. Check the child’s immunization card and local program guidance because schedules and products may change. The current Indian NIS chart is the practical reference.

1. Basic principles of immunization

Definition

Immunization is the process of making a person immune or resistant to an infectious disease, usually by vaccination.
A vaccine is an immunobiological preparation that stimulates specific protective immune responses, including antibodies, cellular immunity, and immunological memory. Vaccines may contain live attenuated organisms, killed organisms, toxoids, purified antigens, recombinant proteins, polysaccharides, or conjugated polysaccharides.
  • Park’s Textbook of Preventive and Social Medicine, chapter on Vaccines.

2. Types of immunization

A. Active immunization

Active immunization means administration of an antigen to induce the person’s own immune response.
Characteristics
  • Protection develops after a lag period, usually days to weeks.
  • Produces immunological memory.
  • Usually long-lasting.
  • Booster doses may be needed.
  • Given by vaccines or following natural infection.
Examples
  • BCG
  • Hepatitis B vaccine
  • DPT/pentavalent vaccine
  • MR/MMR
  • IPV
  • PCV
  • HPV vaccine

B. Passive immunization

Passive immunization means transfer of preformed antibodies to a susceptible person.
Characteristics
  • Protection is immediate.
  • Protection is temporary because no immune memory develops.
  • Used for post-exposure prophylaxis, toxin neutralization, or in immunodeficiency.
Preparations
  1. Human normal immunoglobulin
  2. Specific/hyperimmune immunoglobulin
    • Hepatitis B immunoglobulin (HBIG)
    • Rabies immunoglobulin (RIG)
    • Tetanus immunoglobulin (TIG)
    • Varicella-zoster immunoglobulin
  3. Antisera/antitoxins
    • Diphtheria antitoxin
    • Botulinum antitoxin
    • Snake antivenom
  4. Maternal antibody transfer
    • IgG through placenta
    • Secretory IgA in breast milk

C. Combined active and passive immunization

Both are used when immediate protection and long-term immunity are required.
Examples
  • Rabies exposure: rabies vaccine + RIG for category III exposure
  • Tetanus-prone wound in inadequately immunized child: tetanus vaccine-containing preparation + TIG when indicated
  • Infant born to an HBsAg-positive mother: hepatitis B vaccine + HBIG
Give vaccine and immunoglobulin at different anatomical sites, using separate syringes.

3. Classification of vaccines

TypePrincipleExamplesKey point
Live attenuatedWeak but living organism replicates to a limited extentBCG, OPV, rotavirus, measles, rubella, mumps, varicella, live JEStrong, durable immunity; generally avoid in severe immunodeficiency and pregnancy
Inactivated/killedOrganism has been killed and cannot replicateIPV, inactivated influenza, rabies, hepatitis ASafer in immunodeficiency; usually requires multiple doses/boosters
ToxoidInactivated bacterial toxinTetanus toxoid, diphtheria toxoidProtects against toxin-mediated disease; boosters required
Subunit/recombinantPurified antigen/proteinHepatitis B, HPV, acellular pertussisCannot cause the disease
PolysaccharideCapsular polysaccharide antigenPPSV23, older typhoid polysaccharide vaccineWeak response in children below 2 years; poor memory
ConjugatePolysaccharide linked to protein carrierHib, PCV, typhoid conjugate vaccine, meningococcal conjugate vaccineEffective in infants; produces memory and booster response
Viral vector/mRNAGenetic platform produces antigen in host cellsSome COVID-19 vaccinesProduct and national recommendations vary
Live vaccines generally give more durable immune responses because they mimic natural infection, but they require appropriate storage and have more restrictions in immunocompromised children. Inactivated vaccines cannot replicate and commonly need a primary series plus boosters.
  • The Harriet Lane Handbook, “Immunoprophylaxis.”
  • Park’s Textbook of Preventive and Social Medicine, chapter on Vaccines.

4. Herd immunity

Herd immunity is indirect protection of susceptible people when a sufficiently large proportion of the community is immune, reducing circulation and transmission of an organism.

Importance

  • Protects infants too young to receive vaccines.
  • Protects people with severe immunodeficiency who cannot receive live vaccines.
  • Protects those in whom vaccination did not produce adequate immunity.
  • Helps eliminate or eradicate diseases.

Factors affecting herd immunity

  • Vaccine effectiveness
  • Vaccine coverage
  • Infectiousness of disease, expressed as the basic reproduction number, R₀
  • Duration of immunity
  • Population movement and clustering of unvaccinated individuals
Diseases with very high transmissibility, such as measles, require very high coverage, generally around 95%, to prevent outbreaks.
Herd immunity is not expected with tetanus, because tetanus is acquired from environmental spores and is not transmitted person-to-person.

5. General rules of vaccination

Simultaneous administration

  • Multiple vaccines due at one visit should be given on the same day.
  • Use separate syringes and separate sites.
  • Do not mix vaccines in the same syringe unless supplied as a licensed combination product.
  • This improves completion of the schedule and does not overload the immune system.

Spacing live vaccines

  • Two injectable/nasal live vaccines should be given:
    • on the same day, or
    • separated by at least 4 weeks if not given together.

Interrupted schedules

  • Never restart a vaccine series because of delay.
  • Give the missed dose as soon as possible, observing the required minimum interval.

Mild illness is not a contraindication

Vaccination can usually be given in:
  • Mild fever
  • Common cold/cough
  • Diarrhea without severe dehydration
  • Malnutrition
  • Breastfeeding
  • Stable neurological disease
  • Treatment with antibiotics
  • Prematurity

6. Individual vaccines

A. BCG vaccine

ItemDetails
Full formBacillus Calmette-Guérin
TypeLive attenuated Mycobacterium bovis
Protects mainly againstSevere childhood tuberculosis, especially TB meningitis and miliary TB
UIP ageAt birth or as early as possible until 1 year of age
Dose0.05 mL in infants younger than 1 year; 0.1 mL at 1 year or older
RouteIntradermal
SiteLeft upper arm, insertion of deltoid
ScarUsually develops in 6-12 weeks; its absence alone does not routinely indicate revaccination

Adverse effects

  • Local papule, ulcer, and scar are expected.
  • Regional axillary lymphadenitis may occur.
  • Rare: suppurative lymphadenitis, osteitis, disseminated BCG infection.

Contraindications

  • Severe primary immunodeficiency
  • Severe cellular immunodeficiency
  • Child on significant immunosuppressive therapy
  • Symptomatic HIV infection or known severe immunosuppression, according to national guidance

B. Hepatitis B vaccine

ItemDetails
TypeRecombinant subunit vaccine containing hepatitis B surface antigen
Disease preventedHepatitis B, chronic hepatitis, cirrhosis, hepatocellular carcinoma
UIP scheduleBirth dose, then at 6, 10, and 14 weeks through pentavalent vaccine
Birth dose timingPreferably within 24 hours of birth
DoseUsually 0.5 mL pediatric formulation
RouteIntramuscular
SiteAnterolateral thigh in infants; deltoid in older children

Important points

  • The birth dose is particularly important for prevention of mother-to-child transmission.
  • Preterm and low-birth-weight babies should receive the birth dose according to national policy.
  • If mother is HBsAg-positive, give hepatitis B vaccine plus HBIG as soon as possible, ideally within 12 hours, at different sites.

Adverse effects

  • Mild pain, redness, fever
  • Anaphylaxis is extremely rare.

C. Poliovirus vaccines

1. Oral polio vaccine (OPV)

ItemDetails
TypeLive attenuated oral vaccine
UIP scheduleOPV-0 at birth; OPV-1, 2, 3 at 6, 10, 14 weeks; booster at 16-23 months
Dose2 drops
RouteOral
PurposeProduces intestinal mucosal immunity and helps reduce community transmission
Important: OPV is a live vaccine. Vaccine-associated paralytic poliomyelitis is very rare, but this is why IPV has an important role in polio-endgame strategies.

2. Inactivated polio vaccine (IPV/fIPV)

ItemDetails
TypeInactivated/killed poliovirus vaccine
UIP scheduleFractional IPV at 6 weeks, 14 weeks, and 9-11 months
DosefIPV is 0.1 mL
RouteIntradermal
Usual siteRight upper arm, according to program practice
AdvantageCannot cause vaccine-associated paralytic polio
IPV is safe in immunodeficiency, whereas OPV is generally avoided in children with significant immunodeficiency and in certain high-risk household situations.

D. DPT-containing vaccines and pentavalent vaccine

Components

  • D: Diphtheria toxoid
  • P: Pertussis vaccine, whole-cell or acellular
  • T: Tetanus toxoid
The pentavalent vaccine contains:
  • DPT
  • Hepatitis B
  • Hib
ItemDetails
UIP primary series6, 10, and 14 weeks
Dose0.5 mL
RouteIntramuscular
SiteAnterolateral mid-thigh
UIP boostersDPT booster at 16-23 months and 5-6 years; Td at 10 and 16 years

Diseases prevented

  • Diphtheria
  • Pertussis
  • Tetanus
  • Hepatitis B
  • Invasive Hib disease

Expected adverse effects

  • Pain, redness, swelling
  • Fever, irritability
  • Persistent crying may occur, especially with whole-cell pertussis vaccine.

Important precautions

A previous severe allergic reaction to a vaccine component is a contraindication to further doses of that product. Encephalopathy occurring within 7 days after a pertussis-containing vaccine, without another identifiable cause, is a contraindication to further pertussis-containing doses.

E. Haemophilus influenzae type b vaccine (Hib)

ItemDetails
TypeConjugate vaccine
Given asComponent of pentavalent vaccine under UIP
UIP schedule6, 10, and 14 weeks
Disease preventedHib meningitis, pneumonia, epiglottitis, sepsis, and other invasive Hib disease
Dose/routeUsually 0.5 mL IM as part of combination vaccine
Hib vaccine does not protect against influenza virus. “Hib” refers to Haemophilus influenzae type b, a bacterium.

F. Rotavirus vaccine (RVV)

ItemDetails
TypeLive attenuated oral vaccine
UIP schedule6, 10, 14 weeks
RouteOral
Disease preventedSevere rotavirus gastroenteritis and hospitalization due to diarrhea
Number of dosesDepends on the product and national program; UIP uses 3 doses

Key points

  • Give orally. If the child spits out or regurgitates the dose, do not repeat it.
  • Do not delay unnecessarily because rotavirus products have upper age limits.
  • Contraindications include severe combined immunodeficiency and past intussusception.
  • A small increased risk of intussusception has been reported after some rotavirus vaccines, but the benefits in preventing severe diarrheal disease are far greater.

G. Pneumococcal conjugate vaccine (PCV)

ItemDetails
TypeConjugate vaccine
UIP schedulePCV-1 at 6 weeks, PCV-2 at 14 weeks, booster at 9-11 months
Dose0.5 mL
RouteIntramuscular
SiteAnterolateral thigh
Disease preventedInvasive pneumococcal disease, meningitis, bacteremia, pneumonia, and some otitis media

High-risk children

Children with asplenia, cochlear implant, CSF leak, chronic cardiac/pulmonary disease, chronic kidney disease, diabetes, immunodeficiency, HIV, malignancy, or transplant may need additional pneumococcal vaccination, including PPSV23, based on specialist advice.

H. Measles-rubella vaccine (MR)

ItemDetails
TypeLive attenuated vaccine
UIP scheduleMR-1 at 9-11 months; MR-2 at 16-23 months
Dose0.5 mL
RouteSubcutaneous
SiteRight upper arm
Diseases preventedMeasles and rubella

Importance

  • Measles can cause pneumonia, diarrhea, encephalitis, malnutrition, blindness, and death.
  • Rubella infection during pregnancy can lead to congenital rubella syndrome. Childhood vaccination helps prevent this.

Adverse effects

  • Fever, mild rash, transient lymphadenopathy
  • Febrile seizures may occur rarely.
  • Thrombocytopenia is rare.

Contraindications

  • Pregnancy
  • Severe immunodeficiency
  • Previous anaphylaxis to a vaccine component
  • Defer after some immunoglobulin or blood-product exposures, because passively acquired antibody can reduce response.

I. MMR vaccine

ItemDetails
ComponentsMeasles, mumps, rubella
TypeLive attenuated
Use in IndiaCommonly recommended in private/IAP practice; UIP provides MR rather than MMR
Dose0.5 mL SC
SiteUpper arm
MMR adds protection against mumps, including mumps meningitis, orchitis, and hearing loss.
The exact MMR schedule should follow the current pediatrician/IAP recommendation and vaccine product instructions.

J. Japanese encephalitis vaccine

ItemDetails
Indication in UIPOnly in JE-endemic districts/areas
UIP scheduleJE-1 at 9-11 months and JE-2 at 16-23 months
TypeMay be live attenuated or inactivated, depending on program/product
Route/doseProduct-specific
JE is a mosquito-borne viral encephalitis that can cause severe neurological illness, disability, and death. It is not a universal vaccine in all Indian districts under UIP.

K. DPT booster and Td vaccine

DPT booster

AgeVaccine
16-23 monthsDPT booster-1 + OPV booster
5-6 yearsDPT booster-2

Td vaccine

AgeVaccine
10 yearsTd
16 yearsTd
Td contains tetanus toxoid and reduced-dose diphtheria toxoid. It maintains protection against tetanus and diphtheria through adolescence.

7. Additional commonly recommended vaccines

These may not all be supplied through UIP everywhere. Their use depends on IAP recommendations, risk, travel, local epidemiology, product availability, and family preference.

A. Hepatitis A vaccine

ItemDetails
TypeInactivated vaccine or live attenuated vaccine, depending on product
Usual ageFrom 12 months for inactivated vaccine; live product according to label
RouteIM for inactivated vaccine; product-specific for live vaccine
ProtectionHepatitis A and its complications
Inactivated hepatitis A vaccine usually requires 2 doses. Follow the particular product schedule.

B. Typhoid conjugate vaccine (TCV)

ItemDetails
TypeVi polysaccharide conjugated to carrier protein
AgeCan generally be given from 6 months, depending on product
DoseUsually 0.5 mL
RouteIM
ProtectionTyphoid fever due to Salmonella Typhi
TCV is preferred over plain polysaccharide vaccine in young children because it generates T-cell-dependent immunity and immunological memory.

C. Influenza vaccine

ItemDetails
TypeUsually inactivated influenza vaccine for children
AgeFrom 6 months
ScheduleAnnually
First season in child below 9 yearsTwo doses, at least 4 weeks apart, if not previously adequately vaccinated
Dose/routeProduct- and age-specific; usually IM
Annual vaccination is especially important in children with asthma, chronic lung/heart/kidney disease, diabetes, neurological disorders, immunodeficiency, obesity, and those receiving long-term aspirin therapy.

D. Varicella vaccine

ItemDetails
TypeLive attenuated
ProtectionChickenpox and its complications
ScheduleUsually 2 doses, following current pediatric recommendation
RouteSC
Avoid in pregnancy and severe immunodeficiency.

E. Human papillomavirus vaccine (HPV)

ItemDetails
TypeRecombinant virus-like particle vaccine
ProtectionHPV-related cervical, anal, genital, and some oropharyngeal cancers; genital warts depending on product
Best ageBefore exposure to HPV, commonly 9-14 years
RouteIM, deltoid
ScheduleProduct- and age-specific; usually 1 or 2 doses in younger adolescents, with 3 doses for older or immunocompromised recipients
HPV vaccine is prophylactic. It does not treat established HPV infection.

F. Meningococcal vaccine

Vaccine typesMenACWY conjugate; MenB in selected settings
IndicationsHigh-risk children, asplenia, complement deficiency, travelers to epidemic areas, outbreak control, certain hostels/institutions
RouteIM
ScheduleDepends on age, risk, and product

G. Rabies vaccine

Rabies vaccine is not a routine childhood vaccine in India. It is used after exposure and sometimes as pre-exposure prophylaxis in high-risk persons.

After animal bite/exposure

  • Immediate and thorough wound washing with soap and running water for at least 15 minutes.
  • Prompt medical assessment.
  • Rabies vaccine for category II and III exposures.
  • Rabies immunoglobulin for category III exposure, infiltrated into/around wounds whenever anatomically feasible.
Rabies is almost universally fatal after symptoms begin, but it is preventable with correct post-exposure prophylaxis.

8. True contraindications versus false contraindications

Important true contraindications

SituationVaccine concern
Anaphylaxis after a previous dose or known severe allergy to componentDo not give same vaccine/component without expert assessment
Severe immunodeficiencyAvoid most live vaccines
PregnancyAvoid live vaccines
Encephalopathy within 7 days of pertussis vaccine, with no alternative causeDo not give further pertussis-containing vaccine
SCID or previous intussusceptionRotavirus vaccine contraindicated

Conditions that are usually not contraindications

  • Mild fever or common cold
  • Mild diarrhea
  • Antibiotic use
  • Breastfeeding
  • Prematurity
  • Low birth weight
  • Malnutrition
  • Family history of seizures
  • Stable neurological disorder
  • Controlled asthma or allergy
  • Non-anaphylactic egg allergy for most routinely used vaccines

9. Key counseling points for parents

  1. Vaccines are given according to age because young children are at greatest risk of severe infection.
  2. Mild fever, pain, irritability, and swelling after vaccination are common and usually settle within 1-2 days.
  3. Bring the immunization card to every health visit.
  4. If doses were missed, return promptly. The schedule can be continued; it usually does not need restarting.
  5. Seek urgent care for breathing difficulty, facial swelling, persistent lethargy, seizures, persistent inconsolable crying, high fever, or signs of anaphylaxis after vaccination.
  6. Continue breastfeeding and normal feeding after vaccination.
  7. Oral polio drops should still be taken during Pulse Polio rounds even if the child has received routine OPV/IPV doses.
A recent systematic review found that interventions such as caregiver education, reminder systems, outreach, and reducing access barriers can improve routine childhood vaccine uptake in low- and middle-income countries, though the exact effect varies by setting (BMJ Open review).
This is a shared conversation. Sign in to Orris to start your own chat.